MSCI China USA Biotech 65/35 Index
The MSCI China USA Biotech 65/35 Index aims to represent the performance of securities from MSCI Hong Kong Listed Southbound IMI Index and MSCI USA IMI Index with exposure to the GICS® Biotechnology Industry.
Data as of April 30, 2026
* For ESG objective information, please see this page